Bicycle Therapeutics (BCYC) Depreciation & Amortization (CF) (2018 - 2026)

Bicycle Therapeutics' Depreciation & Amortization (CF) history runs 9 years deep, the most recent figure standing at $1.1 million for Q1 2026.

• Quarterly Depreciation & Amortization (CF) fell 30.91% year-over-year to $1.1 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $5.9 million (down 17.24% YoY) and the FY2025 annual result came in at $6.4 million, down 10.48% from the prior year.
• Depreciation & Amortization (CF) was $1.1 million for Q1 2026 at Bicycle Therapeutics, down from $1.3 million in the prior quarter.
• Across five years, Depreciation & Amortization (CF) topped out at $2.2 million in Q3 2024 and bottomed at $422000.0 in Q1 2022.
• A 5-year average of $1.5 million and a median of $1.6 million in 2024 frame the typical range for Depreciation & Amortization (CF).
• Annual changes were most pronounced in 2022 — Depreciation & Amortization (CF) jumped 275.07% — and 2026, when it plunged 30.91%.
• Bicycle Therapeutics' Depreciation & Amortization (CF) stood at $1.4 million in 2022, then increased by 19.34% to $1.7 million in 2023, then gained by 3.02% to $1.7 million in 2024, then retreated by 21.6% to $1.3 million in 2025, then declined by 15.49% to $1.1 million in 2026.
• Business Quant data shows BCYC's Depreciation & Amortization (CF) at $1.1 million in Q1 2026, $1.3 million in Q4 2025, and $1.8 million in Q3 2025.